Clairity's AI predicts breast cancer risk from a single mammogram
Clairity just received FDA De Novo clearance for CLAIRITY BREAST, an AI platform that predicts five-year breast cancer risk directly from a routine screening mammogram. Validated across more than 77,000 mammograms, the model catches subtle pixel-level tissue patterns invisible to the human eye, offering critical early warning for the 85% of patients with no family history.